Faron Pharmaceuticals Oy (LON:FARN – Get Free Report)’s share price passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 208.38 ($2.71) and traded as low as GBX 161.28 ($2.09). Faron Pharmaceuticals Oy shares last traded at GBX 177.50 ($2.30), with a volume of 77,081 shares.
Faron Pharmaceuticals Oy Trading Up 2.9 %
The company has a debt-to-equity ratio of 922.55, a quick ratio of 1.09 and a current ratio of 1.45. The company’s fifty day simple moving average is GBX 207.90 and its 200-day simple moving average is GBX 165.83. The company has a market capitalization of £188.32 million, a P/E ratio of -562.50 and a beta of 0.36.
About Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company’s lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the prevention from cytokine release syndrome (CRS), or ischemia and hyperinflammatory conditions; and Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of tumor-associated macrophages and converts the highly immunosuppressive M2-like macrophages to a pro-inflammatory state to promote immune activation.
Recommended Stories
- Five stocks we like better than Faron Pharmaceuticals Oy
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Texas Roadhouse Stock Steering for New Highs This Year
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- What is the Euro STOXX 50 Index?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.